Grade D Patent Portfolios

88 companies with below average patent strength

Grade D means below-average patent portfolios with limited diversity or significant near-term expirations. Patent Strength Scores are calculated using USPTO PatentsView data.

Companies

4,089

Total Patents

Avg Score

88%

Of All Companies

A B C D F

All Grade D Companies

Company	Patents	Score	Expiring 2yr	Expiring 5yr
Intel	80	49	6	11
Siemens	75	48	6	9
Ford	50	48	3	5
LG	85	47	5	13
Philips	65	47	4	8
Sony	80	46	7	18
Broadcom	65	46	5	6
Boeing	60	46	2	5
Texas Instruments	60	46	3	11
Johnson & Johnson	55	46	0	8
3M	65	45	3	5
Meta	65	45	6	15
Eli Lilly	45	45	3	4
TSMC	70	44	5	15
Panasonic	70	44	7	9
Nvidia	70	44	3	10
BASF	65	44	5	9
Nokia	55	44	5	9
Roche	52	44	1	9
Medtronic	50	44	1	4
AbbVie	48	44	1	2
Ericsson	60	43	4	8
Procter & Gamble	60	43	4	9
Facebook	60	43	3	7
Cisco	55	43	4	7
Honeywell	55	43	3	5
Dow	55	43	4	7
General Motors	55	43	4	7
Oracle	50	43	1	5
HP	50	43	8	10
Merck	48	43	4	11
Boston Scientific	45	43	4	5
Danaher	40	43	0	1
Micron	55	42	3	7
Foxconn	55	42	2	6
Lockheed Martin	50	42	3	7
Applied Materials	50	42	3	6
Pfizer	50	42	3	9
Bayer	50	42	2	5
DuPont	50	42	3	7
BMW	45	42	2	8
Adobe	45	42	2	4
Thermo Fisher	45	42	2	8
BAE Systems	35	42	1	3
Novartis	55	41	3	8
AstraZeneca	48	41	4	6
Abbott	45	41	3	7
Corning	45	41	1	3
Lam Research	40	41	3	6
Dell	35	41	1	4
General Dynamics	35	41	0	3
Illumina	35	41	0	3
Raytheon	45	40	2	7
AMD	45	40	4	7
Sanofi	45	40	2	4
Deere	45	40	3	6
Lenovo	40	40	1	4
Stryker	40	40	5	6
Zimmer Biomet	35	40	1	4
PayPal	35	40	3	7
Uber	30	40	1	5
L3Harris	30	40	0	0
Bio-Rad	30	40	0	3
Becton Dickinson	30	40	2	2
Waters	25	40	1	5
Tesla	40	39	0	3
SAP	40	39	1	5
Illinois Tool Works	35	39	3	5
Agilent	35	39	2	8
Leidos	25	39	0	2
Blue Origin	20	39	2	3
Honda	50	38	5	9
Bristol-Myers Squibb	42	38	6	8
Amgen	40	38	2	6
Caterpillar	40	38	2	6
Northrop Grumman	40	38	2	3
Regeneron	38	38	3	7
Gilead	35	38	2	6
Salesforce	35	38	2	3
Baxter	35	38	0	2
Parker Hannifin	30	38	2	5
SpaceX	30	38	0	0
Roper Technologies	25	38	2	3
Visa	30	37	3	5
Mastercard	28	37	3	4
Emerson	35	36	3	6
Edwards Lifesciences	30	36	0	4
Square	25	36	2	5

Frequently Asked Questions

Grade D (Below Average) indicates below-average patent portfolios with limited diversity or significant near-term expirations. The grade is based on portfolio size (30%), claims breadth (25%), time remaining (25%), and portfolio diversity (20%).

88 of 100 tracked companies currently have a Grade D Patent Strength Score, holding a combined 4,089 patents.

Grade D companies have weaker IP protection. Investors should assess whether the company relies on patents for competitive advantage, as their portfolio may not deter competitors or generate licensing revenue.

Sources: USPTO PatentsView

Last updated: April 2026

/methodology